Rare mixed dementia: A case report

doi:10.4329/wjr.v17.i1.102579

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (147)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-2)

Sum=68

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=57

Publishing Process of This Article

Item

Count

Browse

Download

Sum=16

Jan 28, 2025 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Radiol. Jan 28, 2025; 17(1): 102579
Published online Jan 28, 2025. doi: 10.4329/wjr.v17.i1.102579

Table 2 Test results of autoimmune encephalitis-related antibodies

Tested items	Sample type	Test method	Detection time	Results
Anti-NMDA antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-LGI1 antibody IgG	CSF	CBA	Pre-treatment	1:100 (positive)
Anti-GABAB antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-CASPR2 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-AMPA1 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-AMPA2 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-IgLON5 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-DPPX antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-GlyR1 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-D2R antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-GAD65 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-mGluR5 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-mGluR1 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-Neurexin-3α antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-KLHL11 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-GABAA antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-AQP4 antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-MOG antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-GFAP antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-ganglionic AChR antibody IgG	CSF	CBA	Pre-treatment	Negative
Anti-LGI1 antibody IgG	Serum	CBA	Pre-treatment	1:100 (positive)
Anti-LGI1 antibody IgG	Serum	CBA	Post-treatment	Negative

CSF: Cerebrospinal fluid; CBA: Cell-based assay; NMDA: N-methyl-D-aspartate; LGI1: Leucine-rich glioma inactivated 1; GABAB: γ-amino butyric acid type B; CASPR2: Contactin associated protein 2; AMPA: α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid; IgLON5: Immunoglobulin-like cell adhesion molecule 5; DPPX: Dipeptidyl‐peptidase‐like protein 6; GlyR1: Glycine receptor 1; D2R: Dopamine 2 receptor; GAD65: Glutamic acid decarboxylase65; mGluR5: Metabotropic glutamate receptor 5; mGluR1: Metabotropic glutamate receptor 1; KLHL11: Kelch-like protein 11; GABAA: γ-amino butyric acidtype A; AQP4: Aquaporin 4; MOG: Myelin oligodendrocyte glycoprotein; GFAP: Glial fibrillary acidic protein; AChR: Acetylcholine receptor.

Citation: Chen XH, Xia W, Ma JB, Chen J, Hu J, Shi X, Yu JJ, Gong J, Liu L, Sun YA, Liu ZG. Rare mixed dementia: A case report. World J Radiol 2025; 17(1): 102579
URL: https://www.wjgnet.com/1949-8470/full/v17/i1/102579.htm
DOI: https://dx.doi.org/10.4329/wjr.v17.i1.102579